Dyne Therapeutics Inc.

DYN | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.18

+$0.06 (+0.35%)

Sep 22, 2026, 9:36 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	893.37M	435.45M	121.63M	172.15M	200.83M	300.85M
Short-Term Investments	217.19M	206.82M	1.47M	83.87M	175.75M	44.46M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	15.6M	1.94M	2.32M	2.32M	2.31M	2.3M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	16.03M	17.01M	6.28M	9.58M	383K	n/a
Total Current Assets	1.13B	659.28M	129.38M	265.59M	382.39M	349.09M
Property-Plant & Equipment	44.77M	30.01M	33.39M	38.41M	40.96M	1.95M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	60.37M	31.96M	35.71M	40.73M	43.27M	4.25M
Total Assets	1.19B	691.23M	165.08M	306.33M	425.66M	353.33M
Account Payables	8.08M	6.56M	22.94M	5.26M	4.03M	3.44M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	5M	4.85M	n/a	n/a	n/a	n/a
Other Current Liabilities	37.55M	17.75M	n/a	n/a	n/a	n/a
Total Current Liabilities	50.63M	42.26M	51.1M	28.09M	28.72M	10.97M
Long-Term Debt	15.28M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	148.92M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	164.2M	19.14M	22.7M	25.87M	28.74M	n/a
Total Liabilities	214.83M	61.4M	73.79M	53.96M	57.47M	10.97M
Total Debt	20.28M	23.99M	27.42M	30.48M	32.64M	n/a
Book Value	972.13M	629.84M	91.29M	252.36M	368.2M	342.37M
Book Value Per Share	7.57	6.69	1.53	4.86	7.23	7.24
Common Stock	16K	10K	6K	6K	6K	5K
Retained Earnings	-1.4B	-949.93M	-632.51M	-396.57M	-228.47M	-79.18M
Comprehensive Income	475K	6K	n/a	-571K	-269K	-27K
Shareholders Equity	972.13M	629.84M	91.29M	252.36M	368.2M	342.37M
Total Investments	217.19M	206.82M	1.47M	83.87M	175.75M	44.46M